Sodium Chloride 0.9%: Clinical Trials

95 trials of Sodium Chloride 0.9%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 15 unknown, 10 recruiting, 10 terminated. 32 Phase 3, 25 Phase 2, 25 Phase 4, 9 Not applicable, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 332Completed 16, Terminated 4, Unknown 4, Recruiting 3, Withdrawn 3, Not yet recruiting 2
Phase 225Completed 9, Recruiting 4, Unknown 4, Terminated 3, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1
Phase 425Completed 14, Unknown 7, Terminated 2, Not yet recruiting 1, Recruiting 1
Not applicable9Completed 5, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 16Completed 2, Recruiting 2, Terminated 2
Early Phase 12Completed 2

Follow Sodium Chloride 0.9%: new trials by email Literature Review of Sodium Chloride 0.9% trials Research Report on Sodium Chloride 0.9%

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SCARFREE-001: Verteporfin for Scar Prevention
Verteporfin Injection, Saline injection - Surgical Scar
Phase 2Not yet recruitingOdense University Hospital122026-10-012026-10-05
Outpatient Hypertonic Saline and Loop Diuretic Combination Therapy in Cardiorenal
Hypertonic sodium chloride 10%, Sodium Chloride 0.9%, Furosemide intravenous solution - Heart Failure, Renal Disease, Chronic
Phase 3Not yet recruitingUniversity of Monastir602026-09-012026-07-15
Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy
Sodium Chloride 0.9%, Dexamethasone, Chloroprocaine Injection [Clorotekal] - Knee Arthroscopy
Phase 3Not yet recruitingCMC Ambroise Paré602026-09-012026-06-29
Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine
LTB-NG6, Sodium Chloride 0.9% - Neisseria Gonorrhea
Phase 1RecruitingLimmaTech Biologics AG1422026-08-192026-09-23
NON-SURGİCAL PERİODONTAL THERAPY WİTH L-ARGİNİNE
L-arginine 0.8% subgingival irrigation, Saline 0.9% subgingival irrigation (placebo), Scaling and root planing - Periodontal Disease, Periodontal Diseases
Not applicableActive not recruitingAlanya Alaaddin Keykubat University602026-06-012026-10-23
Intravenous Dexamethasone as an Adjuvant to Dexmedetomidine After Superior Trunk Block for Arthroscopic Shoulder Surgery
Dexamethasone, Dexmedetomidine, Sodium Chloride 0.9% - Postoperative Pain
Not applicableNot yet recruitingRecep Karakaşoğlu702026-04-252026-04-13
Comparison of Postoperative Pain After Root Canal Irrigation in Symptomatic Irreversible Pulpitis
Dexamethasone, Sodium Chloride 0.9% - Symptomatic Irreversible Pulpitis
Not applicableCompletedCMH Lahore Medical College and Institute of Dentistry722026-02-282026-10-22
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis
Phase 1 / Phase 2RecruitingDavid K Carroll602025-12-192026-02-12
The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis
120mg methylprednisolone acetate, 40mg methylprednisolone acetate, Placebo - Hand Osteoarthritis
Phase 3RecruitingSint Maartenskliniek2122025-10-282026-01-28
COMPASS - COpenhagen MenoPAuSe Study
Triptorelin 11.25 mg, Sodium Chloride 0.9%, Estradiol (E2) - Menopausal Osteoporosis, Bone Markers
Phase 2RecruitingMartin Blomberg Jensen1922025-10-022026-03-02
Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis
NG01 - Autologous bone marrow derived human stromal cells, Sodium Chloride 0.9% - Secondary Progressive Multiple Sclerosis (SPMS)
Phase 2Not yet recruitingNeuroGenesis Ltd.452025-10-012025-05-07
LIDOCRIT : Effect of Continuous Intravenous LIDOcaine on Discomfort in Postoperative CRITical Care Inpatients
Lidocaine (drug), Placebo - Post-surgery Critical Incare
Phase 4Not yet recruitingRennes University Hospital2462025-10-012025-07-04
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Biospecimen Collection, Distal Pancreatectomy, Lanreotide - Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3RecruitingSWOG Cancer Research Network2742025-05-092026-03-31
Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy
Levobupivacaine Hydrochloride 0.25 % Injectable Solution, Sodium chloride 0.9% - Analgesic Effect
Phase 4RecruitingAlgemeen Ziekenhuis Maria Middelares1442024-09-012024-09-19
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
Amiodarone Hydrochloride, Saline - Atrial Fibrillation, Esophageal Carcinoma
Phase 2RecruitingOHSU Knight Cancer Institute902024-06-212026-05-22
IVIG for Infection Prevention After CAR-T-Cell Therapy
Immune Globulin Infusion (Human), 10% Solution, Anti-CD19 CAR T Cells Preparation, Saline - Hematologic Malignancies
Phase 2RecruitingFred Hutchinson Cancer Center1502024-06-102026-06-29
Effect of Single-Dose Dexamethasone on Postoperative Pain After Cesarean Section Under Spinal Anesthesia
Dexamethasone (IV), Normal Saline 0.9% Infusion Solution - Spinal Anesthesia, Cesarean Section Pain
Phase 4CompletedKRL Hospital, Islamabad802024-03-012026-07-21
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
Calcium Gluconate 10%, sodium chloride 0.9% - Elective Cesarean Delivery
Not applicableRecruitingRambam Health Care Campus11802023-11-142026-07-16
Impact of Topical Tranexamic Acid in Breast Reconstruction
Tranexamic Acid, Saline - Breast Cancer
Phase 4TerminatedUniversity of California, San Francisco232023-04-202025-09-29
Peroperative Administration of Tranexamic Acid in Roux-en-Y Gastric Bypass and One-anastomosis Gastric Bypass
Tranexamic Acid Injection [Cyklokapron], Sodium chloride 0.9% - Hemorrhage, Bleeding
Phase 3UnknownFranciscus Gasthuis15242022-09-012022-07-19

Showing 20 of 95. Sign in to see all of them.

Conditions studied

Pain, Postoperative (6)  ·  Breast Neoplasms (4)  ·  Heart Failure (4)  ·  COVID-19 (3)  ·  Hemorrhage (3)  ·  Inflammation (3)  ·  ST Elevation Myocardial Infarction (3)  ·  Stroke (3)  ·  Acute Kidney Injury (2)  ·  Atrial Fibrillation (2)  ·  Brain Injuries, Traumatic (2)  ·  Delirium (2)  ·  Esophageal Neoplasms (2)  ·  Iron Deficiencies (2)  ·  Myocardial Infarction (2)

Sponsors

CMC Ambroise Paré (4)  ·  Stem Cell Therapeutics Corp. (3)  ·  University Hospital, Basel, Switzerland (3)  ·  Australian and New Zealand Intensive Care Research Centre (2)  ·  Jazz Pharmaceuticals (2)  ·  Northwestern University (2)  ·  Region Örebro County (2)  ·  3M (1)  ·  AIDS Malignancy Consortium (1)  ·  Ain Shams University (1)  ·  Alanya Alaaddin Keykubat University (1)  ·  Albina Nowak, MD (1)  ·  Algemeen Ziekenhuis Maria Middelares (1)  ·  Amicus Therapeutics (1)  ·  Baylor College of Medicine (1)

Countries

United States (28)  ·  France (15)  ·  Germany (6)  ·  Switzerland (6)  ·  Netherlands (5)  ·  United Kingdom (5)  ·  Australia (4)  ·  Canada (4)  ·  Finland (4)  ·  Israel (4)  ·  Denmark (3)  ·  New Zealand (3)  ·  Norway (3)  ·  Saudi Arabia (3)  ·  Austria (2)

Top investigators

Michael D Hill, MD (2)  ·  Steven C Cramer, MD (2)  ·  Adnan Iqbal, MD (1)  ·  Adrian Corneliu Iancu, M.D, Ph.D (1)  ·  Alan Peaceman, MD (1)  ·  Albina Nowak, MD (1)  ·  Alistair D Nichol, MD (1)  ·  Anders Opdahl, MD, PhD (1)  ·  Associate Professor Craig French (1)  ·  Bala Venkatesh (1)  ·  Bart Vaes, MD (1)  ·  Bart de Keulenaer (1)  ·  Belaid BB Bouhemad, PU-PH (1)

Results publications

PMID 26452709, PMID 15920188, PMID 18063608, PMID 18465717, PMID 20554319, PMID 21345435, PMID 21439633, PMID 21559279, PMID 21675055, PMID 21702233, PMID 23075127, PMID 23477634, PMID 23731998, PMID 23872605, PMID 24042386, PMID 24261644, PMID 24588854, PMID 25498484, PMID 25528574, PMID 25662592, PMID 25884605, PMID 26751635, PMID 27324967, PMID 28143564, PMID 28843536, PMID 29466591, PMID 29700898, PMID 29939279, PMID 30132785, PMID 30642657, PMID 30975645, PMID 31042669, PMID 31673391, PMID 32005192, PMID 32171721, PMID 32172314, PMID 32194058, PMID 32247156, PMID 32275191, PMID 32312288, PMID 32335895, PMID 32492040, PMID 33087480, PMID 33253391, PMID 33345865, PMID 33566466, PMID 33648563, PMID 33719606, PMID 33781988, PMID 33846498

NIH funding

2017 (3), 2019 (3), 2015 (2), 2016 (2), 2025 (2), 2008 (1), 2023 (1), N01CN00042 (1), P30CA015083 (1), R01CA276040 (1), UG1CA189974 (1), UM1CA121947 (1)